(Q37785813)

23 August 2017

title

Neuroimmune pharmacology of neurodegenerative and mental diseases (English)

1 reference

23 August 2017

Neuroimmune Pharmacology of Neurodegenerative and Mental Diseases (English)

1 reference

https://api.crossref.org/works/10.1007/S11481-010-9241-8

7 July 2024

1 reference

1 reference

Feng-Shiun Shie

1

1 reference

23 August 2017

Yun-Hsiang Chen

series ordinal

2

1 reference

23 August 2017

Chia-Hsiang Chen

series ordinal

3

1 reference

23 August 2017

Ing-Kang Ho

series ordinal

4

1 reference

23 August 2017

language of work or name

1 reference

7 September 2010

1 reference

full work available at URL

23 August 2017

http://link.springer.com/content/pdf/10.1007/s11481-010-9241-8.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1007/S11481-010-9241-8

http://link.springer.com/article/10.1007/s11481-010-9241-8/fulltext.html

7 July 2024

1 reference

https://api.crossref.org/works/10.1007/S11481-010-9241-8

http://link.springer.com/content/pdf/10.1007/s11481-010-9241-8

7 July 2024

1 reference

https://api.crossref.org/works/10.1007/S11481-010-9241-8

Journal of Neuroimmune Pharmacology

7 July 2024

published in

1 reference

23 August 2017

volume

6

1 reference

23 August 2017

issue

1

1 reference

23 August 2017

page(s)

28-40

1 reference

Migration and differentiation of neural precursor cells can be directed by microglia

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Functional diversity of helper T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Celecoxib as adjunctive therapy in schizophrenia: a double-blind, randomized and placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Cocaine-mediated enhancement of Tat toxicity in rat hippocampal cell cultures: the role of oxidative stress and D1 dopamine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

The Neuropathology of HIV/AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Updated research nosology for HIV-associated neurocognitive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Novel regimens and delivery systems in the pharmacological treatment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

The blood brain barrier in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Nuclear localization of HIV-1 tat functionalized gold nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Early-life programming of later-life brain and behavior: a critical role for the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Microglia-mediated neurotoxicity: uncovering the molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Drugs of abuse, immune modulation, and AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Timing and specificity of the cognitive changes induced by interleukin-2 and interferon-alpha treatments in cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Treatment of adult systemic mastocytosis with interferon-alpha: results of a multicentre phase II trial on 20 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Cytokine profiles in schizophrenic patients treated with risperidone: a 3-month follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Cognitive deficits and degeneration of interneurons in HIV+ methamphetamine users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Improved control of osteoarthritis pain and self-reported health status in non-responders to celecoxib switched to rofecoxib: results of PAVIA, an open-label post-marketing survey in Spain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Neuropsychological functioning and antiretroviral treatment in HIV/AIDS: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Roles of MCP-1 in development of HIV-dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Macrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of neuroAIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Cytokines in schizophrenia and the effects of antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Mechanisms of HIV-1 neurotropism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

MRP (ABCC) transporters-mediated efflux of anti-HIV drugs, saquinavir and zidovudine, from human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Minocycline does not affect amyloid beta phagocytosis by human microglial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Minocycline reduces microglial activation and improves behavioral deficits in a transgenic model of cerebral microvascular amyloid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Infliximab improves health-related quality of life in the presence of comorbidities among patients with moderate-to-severe psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Neuroscience. Brain under surveillance: the microglia patrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Microbial Infections, Immunomodulation, and Drugs of Abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Addictive drugs and their relationship with infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Blood?Brain Barrier Transport of Kynurenines: Implications for Brain Synthesis and Metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Immunity and schizophrenia: autoimmunity, cytokines, and immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Curcumin, the active constituent of turmeric, inhibits amyloid peptide-induced cytochemokine gene expression and CCR5-mediated chemotaxis of THP-1 monocytes by modulating early growth response-1 transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Mechanisms underlying inflammation in neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Disease modifying therapy for AD?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Neurocognitive disturbances in HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Integrated brain circuits: astrocytic networks modulate neuronal activity and behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Glutamate, a neurotransmitter--and so much more. A synopsis of Wierzba III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Immune cytokines and regulation of body temperature, food intake and cellular immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Neuroprotective effect of curcumin on focal cerebral ischemic rats by preventing blood-brain barrier damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Curcumin suppresses lipopolysaccharide-induced cyclooxygenase-2 expression by inhibiting activator protein 1 and nuclear factor kappab bindings in BV2 microglial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Effects of antidepressants on the production of cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Effect of risperidone on serum cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Inhibition of GSK-3beta mediates expression of MMP-9 through ERK1/2 activation and translocation of NF-kappaB in rat primary astrocyte

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Naturally occurring phytochemicals for the prevention of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

A coat of many colors: neuroimmune crosstalk in human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Cytokines and the brain: implications for clinical psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Effects of serotonin and serotonergic agonists and antagonists on the production of interferon-gamma and interleukin-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Abeta42 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Chronic morphine exposure causes pronounced virus replication in cerebral compartment and accelerated onset of AIDS in SIV/SHIV-infected Indian rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Lithium improves HIV-associated neurocognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Antioxidant and antiinflammatory activities of xanthorrhizol in hippocampal neurons and primary cultured microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

The phenomenology and treatment of interferon-induced depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Regulation of inflammatory response in neural cells in vitro by thiadiazolidinones derivatives through peroxisome proliferator-activated receptor gamma activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Evidence for an immune response in major depression: a review and hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Increased serum interleukin-8 and interleukin-10 in schizophrenic patients resistant to treatment with neuroleptics and the stimulatory effects of clozapine on serum leukemia inhibitory factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Mood disorders associated with interferon treatment: theoretical and practical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

First non-ATP competitive glycogen synthase kinase 3 beta (GSK-3beta) inhibitors: thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Neuroendocrine immune interactions in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

NSAIDs and Alzheimer disease: epidemiological, animal model and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Memantine upregulates BDNF and prevents dopamine deficits in SIV-infected macaques: a novel pharmacological action of memantine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Norman Cousins Lecture. Mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Telmisartan prevented cognitive decline partly due to PPAR-gamma activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Plasma levels of interleukin-6 and tumor necrosis factor alpha in chronic schizophrenia: effects of clozapine treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Old drug, new tricks: haloperidol inhibits secretion of proinflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

COX-2 inhibitors as adjunctive therapy in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Methamphetamine enhances HIV-1 infectivity in monocyte derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Evolution of HIV dementia with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Interleukin-6 production by astrocytes: induction by the neurotransmitter norepinephrine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

NanoART, neuroAIDS and CNS drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Cytokines: abnormalities in major depression and implications for pharmacological treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Increased tumor necrosis factor-alpha concentrations with interleukin-4 concentrations in exacerbations of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Antipsychotic treatment may alter T-helper (TH) 2 arm cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Dopamine prevents nitration of tyrosine hydroxylase by peroxynitrite and nitrogen dioxide: is nitrotyrosine formation an early step in dopamine neuronal damage?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Towards a unified model of neuroendocrine-immune interaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Effects of clozapine on plasma cytokine and soluble cytokine receptor levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Redox modulation of chromatin remodeling: impact on histone acetylation and deacetylation, NF-kappaB and pro-inflammatory gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Tumour necrosis factor alpha induces rapid reduction in AMPA receptor-mediated calcium entry in motor neurones by increasing cell surface expression of the GluR2 subunit: relevance to neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Decreased T cellular immune response in schizophrenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Review of immunological and immunopathological findings in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Modulation of immune function by morphine: implications for susceptibility to infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Fluoxetine and citalopram exhibit potent antiinflammatory activity in human and murine models of rheumatoid arthritis and inhibit toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

The neurologic basis of fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

The anti-inflammatory effects of prostaglandins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Valproic acid adjunctive therapy for HIV-associated cognitive impairment: a first report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Role of astrocytes in the maintenance and modulation of glutamatergic and GABAergic neurotransmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Role of astrocytic transport processes in glutamatergic and GABAergic neurotransmission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Manipulation of microglial activation as a therapeutic strategy in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Side effects of interferon-alpha therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

A glutamatergic component of lead toxicity in adult brain: the role of astrocytic glutamate transporters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Cytokines and the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Evidence for an inhibitory immunomodulatory effect of selected antidepressants on rat splenocytes: possible relevance to depression and hyperactive-immune disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Stimulation of microglial metabotropic glutamate receptor mGlu2 triggers tumor necrosis factor alpha-induced neurotoxicity in concert with microglial-derived Fas ligand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Drugs of abuse and dysfunction of neuroendocrine and immune systems: the importance of animal research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Regulation of the HPA axis by cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Glutamate transporters: confining runaway excitation by shaping synaptic transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Crystal methamphetamine, its analogues, and HIV infection: medical and psychiatric aspects of a new epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

The transport of anti-HIV drugs across blood-CNS interfaces: summary of current knowledge and recommendations for further research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

"Inflammatory" cytokines: neuromodulators in normal brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Cytokines and their role in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

CNS inflammation and macrophage/microglial biology associated with HIV-1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Cocaine opens the blood-brain barrier to HIV-1 invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Changes in serum interleukin-2, -6, and -8 levels before and during treatment with risperidone and haloperidol: relationship to outcome in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Neuroprotective and anti-human immunodeficiency virus activity of minocycline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

In vivo immunomodulatory effects of clozapine in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

CSF Prostaglandin Levels in Depressed and Schizophrenic Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9241-8

Microglial cells in neurodegenerative disorders.

21 January 2018

1 reference

12 December 2020

Plasma levels of cytokines and soluble cytokine receptors during treatment with olanzapine

1 reference

12 December 2020

Role of protein kinase C and cAMP in fluoxetine effects on human T-cell proliferation

1 reference

12 December 2020

Probable deceleration of progression of Simian AIDS affected by opiate dependency: studies with a rhesus macaque/SIVsmm9 model

1 reference

12 December 2020

Effects on the immune system.

1 reference

12 December 2020

Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders.

1 reference

12 December 2020

Increased level of salivary prostaglandins in patients with major depression

1 reference

12 December 2020

Differential effect of IFNalpha-2b on the cytochrome P450 enzyme system: a potential basis of IFN toxicity and its modulation by other drugs.

1 reference

12 December 2020

Cerebrospinal fluid cytokines in pediatric neuropsychiatric disease

1 reference

12 December 2020

Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine

1 reference

12 December 2020

The role of indoleamine 2,3-dioxygenase (IDO) in the pathophysiology of interferon-alpha-induced depression

1 reference

12 December 2020

Tricyclic antidepressants inhibit IL-6, IL-1 beta and TNF-alpha release in human blood monocytes and IL-2 and interferon-gamma in T cells

1 reference

12 December 2020

Critical role of microglial NADPH oxidase-derived free radicals in the in vitro MPTP model of Parkinson's disease.

1 reference

12 December 2020

Neurologic manifestations of AIDS.

1 reference

12 December 2020

Changes in histamine and serotonin secretion from rat peritoneal mast cells caused by antidepressants

1 reference

12 December 2020

Anti-inflammatory activities of cAMP-elevating agents: enhancement of IL-10 synthesis and concurrent suppression of TNF production.

1 reference

12 December 2020

Depression, immunocompetence, and prostaglandins of the E series

1 reference

12 December 2020

Effects of etanercept therapy on fatigue and symptoms of depression in subjects treated for moderate to severe plaque psoriasis for up to 96 weeks

1 reference

12 December 2020

Glia: the many ways to modulate synaptic plasticity

1 reference

12 December 2020

Relationships between interleukins, neurotransmitters and psychopathology in drug-free male schizophrenics

1 reference

12 December 2020

Immunomodulatory effect of selective serotonin reuptake inhibitors (SSRIs) on human T lymphocyte function and gene expression

1 reference

12 December 2020

Differential effect of chronic antidepressant treatments on lipopolysaccharide-induced depressive-like behavioural symptoms in the rat

1 reference

12 December 2020

Serum levels of soluble IL-2 receptor alpha, IL-6 and IL-1 receptor antagonist in schizophrenia before and during neuroleptic administration

1 reference

12 December 2020

Alzheimer's disease: genes, proteins, and therapy

1 reference

12 December 2020

Microglial activation and beta -amyloid deposit reduction caused by a nitric oxide-releasing nonsteroidal anti-inflammatory drug in amyloid precursor protein plus presenilin-1 transgenic mice.

1 reference

12 December 2020

Expression of 5HT1a receptors on activated human T cells. Regulation of cyclic AMP levels and T cell proliferation by 5-hydroxytryptamine

1 reference

12 December 2020

High-affinity uptake of L-kynurenine by a Na+-independent transporter of neutral amino acids in astrocytes

1 reference

12 December 2020

The immune system and schizophrenia. An integrative view.

1 reference

12 December 2020

Cytokine network in the central nervous system and its roles in growth and differentiation of glial and neuronal cells

1 reference

12 December 2020

Differential regulation of IFN-gamma, IL-10 and inducible nitric oxide synthase in human T cells by cyclic AMP-dependent signal transduction pathway

1 reference

12 December 2020

Alcohol's contribution to compromised immunity.

1 reference

12 December 2020

The naming of cats--and alpha-interferons

1 reference

12 December 2020

The HIV-1 associated dementia complex: a metabolic encephalopathy fueled by viral replication in mononuclear phagocytes.

1 reference

12 December 2020

Human brain parenchymal microglia express CD14 and CD45 and are productively infected by HIV-1 in HIV-1 encephalitis

1 reference

12 December 2020

Plasma levels of cytokines and soluble cytokine receptors during treatment with haloperidol

1 reference

12 December 2020

Glial cell reactions in neurodegenerative diseases: pathophysiology and therapeutic interventions.

1 reference

12 December 2020

Increased serum IgE in schizophrenic patients who responded poorly to neuroleptic treatment

1 reference

12 December 2020

Journal of Psychiatry & Neuroscience

161

29

11

MC Wichers

2004

1 reference

https://api.crossref.org/works/10.1007/S11481-010-9241-8

7 July 2024

Identifiers

1 reference

23 August 2017

1 reference